Rui Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Epithelial Mesenchymal Transition

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Shirui Wang, Zhanzhan Feng, Can Qu, Su Yu, Hongjia Zhang, Rui Deng, Dan Luo, Chunlan Pu, Yan Zhang, Rui Li
Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation. Journal of medicinal chemistry (2024)
Hongjia Zhang, Yan Zhang, Zhanzhan Feng, Ming Shuai, Xinyu Ma, Shirui Wang, Su Yu, Rui Deng, Dan Luo, Jianyou Shi, Chunlan Pu, Rui Li
Discovery of Novel Proteolysis-Targeting Chimera Molecules as Degraders of Programmed Cell Death-Ligand 1 for Breast Cancer Therapy. Journal of medicinal chemistry 67 (13) (2024)
Shirui Wang, Zhanzhan Feng, Can Qu, Su Yu, Hongjia Zhang, Rui Deng, Dan Luo, Chunlan Pu, Yan Zhang, Rui Li
Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation. Journal of medicinal chemistry 67 (12) (2024)
Hongjia Zhang, Yan Zhang, Zhanzhan Feng, Ming Shuai, Xinyu Ma, Shirui Wang, Su Yu, Rui Deng, Dan Luo, Jianyou Shi, Chunlan Pu, Rui Li
Discovery of Novel Proteolysis-Targeting Chimera Molecules as Degraders of Programmed Cell Death-Ligand 1 for Breast Cancer Therapy. Journal of medicinal chemistry 67 (13) (2024)
Shirui Wang, Zhanzhan Feng, Can Qu, Su Yu, Hongjia Zhang, Rui Deng, Dan Luo, Chunlan Pu, Yan Zhang, Rui Li
Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation. Journal of medicinal chemistry 67 (12) (2024)
Hongjia Zhang, Yan Zhang, Zhanzhan Feng, Ming Shuai, Xinyu Ma, Shirui Wang, Su Yu, Rui Deng, Dan Luo, Jianyou Shi, Chunlan Pu, Rui Li
Discovery of Novel Proteolysis-Targeting Chimera Molecules as Degraders of Programmed Cell Death-Ligand 1 for Breast Cancer Therapy. Journal of medicinal chemistry (2024)
Jie Yang, Yuanyuan Liu, Suke Lan, Su Yu, Xinyu Ma, Dan Luo, Huifang Shan, Xinxin Zhong, Guoyi Yan, Rui Li
Discovery of 2-Methyl-2-(4-(2-methyl-8-(1 H -pyrrolo[2,3- b ]pyridin-6-yl)-1 H -naphtho[1,2- d ]imidazol-1-yl)phenyl)propanenitrile as a Novel PI3K/mTOR Inhibitor with Enhanced Antitumor Efficacy In Vitro and In Vivo . Journal of medicinal chemistry 65 (19) (2022)